Abstract
OBJECTIVE: To review indications for assessing bone mineral density (BMD) and to review patient characteristics and diseases associated with osteoporosis. QUALITY OF EVIDENCE: This paper is based on data from longitudinal observational studies of how BMD and other risk factors affect development of fragility fractures and on several peer-reviewed publications describing pathophysiology of bone turnover and pathogenesis of osteoporosis. Indications for obtaining BMD and monitoring treatment are based on the recommendations of the Osteoporosis Society of Canada derived from the consensus opinion of a panel of experts in osteoporosis and based on their review of the primary literature. MAIN MESSAGE: Measurement of BMD provides the best single objective predictor of the relative risk of fracture at sites such as the vertebrae, hip, and wrist, predicting the likelihood of fracture with as much accuracy as measurement of elevated blood pressure predicts stroke. In addition to making the diagnosis of osteoporosis, BMD measurements are used to monitor progression of osteoporosis and effects of therapy. At this date, dual energy x-ray absorptiometry is preferred for measuring BMD. The most likely causes of osteoporosis in any patient are age, hormone withdrawal (in both men and women), and drugs (particularly corticosteroids). Secondary causes, particularly hyperparathyroidism and multiple myeloma, should be excluded by performing appropriate laboratory tests. CONCLUSION: A BMD measurement should be obtained for patients at high risk of osteoporosis and fragility fractures to guide initiation and monitor success of therapy.
Full Text
The Full Text of this article is available as a PDF (51.8 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cummings S. R., Black D. M., Nevitt M. C., Browner W., Cauley J., Ensrud K., Genant H. K., Palermo L., Scott J., Vogt T. M. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet. 1993 Jan 9;341(8837):72–75. doi: 10.1016/0140-6736(93)92555-8. [DOI] [PubMed] [Google Scholar]
- Cummings S. R., Nevitt M. C., Browner W. S., Stone K., Fox K. M., Ensrud K. E., Cauley J., Black D., Vogt T. M. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995 Mar 23;332(12):767–773. doi: 10.1056/NEJM199503233321202. [DOI] [PubMed] [Google Scholar]
- Gärdsell P., Johnell O., Nilsson B. E. Predicting fractures in women by using forearm bone densitometry. Calcif Tissue Int. 1989 Apr;44(4):235–242. doi: 10.1007/BF02553757. [DOI] [PubMed] [Google Scholar]
- Harris S., Dawson-Hughes B. Rates of change in bone mineral density of the spine, heel, femoral neck and radius in healthy postmenopausal women. Bone Miner. 1992 Apr;17(1):87–95. doi: 10.1016/0169-6009(92)90713-n. [DOI] [PubMed] [Google Scholar]
- Hochberg M. C., Ross P. D., Black D., Cummings S. R., Genant H. K., Nevitt M. C., Barrett-Connor E., Musliner T., Thompson D. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum. 1999 Jun;42(6):1246–1254. doi: 10.1002/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
- Hui S. L., Slemenda C. W., Johnston C. C., Jr Baseline measurement of bone mass predicts fracture in white women. Ann Intern Med. 1989 Sep 1;111(5):355–361. doi: 10.7326/0003-4819-111-5-355. [DOI] [PubMed] [Google Scholar]
- Levis S., Altman R. Bone densitometry: clinical considerations. Arthritis Rheum. 1998 Apr;41(4):577–587. doi: 10.1002/1529-0131(199804)41:4<577::AID-ART4>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]
- Liel Y., Edwards J., Shary J., Spicer K. M., Gordon L., Bell N. H. The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women. J Clin Endocrinol Metab. 1988 Jun;66(6):1247–1250. doi: 10.1210/jcem-66-6-1247. [DOI] [PubMed] [Google Scholar]
- Melton L. J., 3rd, Atkinson E. J., O'Fallon W. M., Wahner H. W., Riggs B. L. Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res. 1993 Oct;8(10):1227–1233. doi: 10.1002/jbmr.5650081010. [DOI] [PubMed] [Google Scholar]
- Miller P. D., Zapalowski C., Kulak C. A., Bilezikian J. P. Bone densitometry: the best way to detect osteoporosis and to monitor therapy. J Clin Endocrinol Metab. 1999 Jun;84(6):1867–1871. doi: 10.1210/jcem.84.6.5710. [DOI] [PubMed] [Google Scholar]
- Pouilles J. M., Ribot C., Trémollières F., Bonneu M., Brun S. Facteurs de risque de l'ostéoporose vertébrale. Résultats d'une étude de 2,279 femmes adressées à une consultation de ménopause. Rev Rhum Mal Osteoartic. 1991 Mar;58(3):169–177. [PubMed] [Google Scholar]
- Ross P. D. Risk factors for osteoporotic fracture. Endocrinol Metab Clin North Am. 1998 Jun;27(2):289–301. doi: 10.1016/s0889-8529(05)70006-2. [DOI] [PubMed] [Google Scholar]
- Slemenda C. W., Hui S. L., Longcope C., Wellman H., Johnston C. C., Jr Predictors of bone mass in perimenopausal women. A prospective study of clinical data using photon absorptiometry. Ann Intern Med. 1990 Jan 15;112(2):96–101. doi: 10.7326/0003-4819-112-2-96. [DOI] [PubMed] [Google Scholar]
- Spector T. D., Keen R. W., Arden N. K., Morrison N. A., Major P. J., Nguyen T. V., Kelly P. J., Baker J. R., Sambrook P. N., Lanchbury J. S. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ. 1995 May 27;310(6991):1357–1360. doi: 10.1136/bmj.310.6991.1357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wasnich R. D., Ross P. D., Heilbrun L. K., Vogel J. M. Prediction of postmenopausal fracture risk with use of bone mineral measurements. Am J Obstet Gynecol. 1985 Dec 1;153(7):745–751. doi: 10.1016/0002-9378(85)90338-2. [DOI] [PubMed] [Google Scholar]